Literature DB >> 8582100

Paf antagonists block induction of nitric oxide synthase in cultured macrophages and vascular smooth muscle cells.

J F Arthur1, S Shahin, G J Dusting.   

Abstract

1. Nitric oxide (NO) synthase inhibitors and Paf antagonists abrogate hypotension in septic shock. The latter may act by blocking intracellular transduction mechanisms in vascular smooth muscle cells and inflammatory cells. We examined the effect of Paf antagonists on expression of inducible NO synthase. 2. A murine macrophage cell line (J774.2) and rat vascular smooth muscle cells (VSMC) were stimulated with lipopolysaccharide (LPS), either alone or in combination with Paf or Paf antagonists, BN 50739 or E-6123. 3. NO synthase activity in J774.2 was measured by the conversion of [3H]L-arginine to [3H]L-citrulline. Nitrite accumulation was measured in the culture medium of J774.2 and VSM. 4. BN 50739 (10 mumol/L and E-6123 (1 mumol#L) both reduced the expression of calcium-independent NO synthase activity and nitrite accumulation, while Paf alone had no effect. 5. Inhibition of NO synthase induction by Paf antagonists might afford therapeutic benefits in the management of septic shock and possibly other cardiovascular disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8582100     DOI: 10.1111/j.1440-1681.1995.tb02041.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  3 in total

1.  Platelet-activating factor evokes Ca2+ transients after the blockade of ryanodine receptor by dantrolene in RAW 264.7 macrophages.

Authors:  B Lendvai; E Sántha; J Szelényi; G Haskó
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

2.  Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms.

Authors:  G J Dusting; K Akita; H Hickey; M Smith; V Gurevich
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

3.  Nitric oxide plays a key role in the platelet-activating factor-induced enhancement of resistance against systemic candidiasis.

Authors:  Han-A Kim; So-Hee Kim; Hyun-Mi Ko; Jung-Hwa Choi; Kyoung-Jin Kim; Sin-Hye Oh; Kyoung-Oh Cho; Il-Whan Choi; Suhn-Young Im
Journal:  Immunology       Date:  2008-04-04       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.